More Information
A note on effectiveness of dry cow therapy in New Zealand dairy herds
Authors: Duirs G, Barker RM, Pankey JW, Twomey APublication: New Zealand Veterinary Journal, Volume 30, Issue 4, pp 50-52, Apr 1982
Publisher: Taylor and Francis
Animal type: Cattle, Livestock, Production animal, Ruminant
Subject Terms: Animal remedies/veterinary medicines, Antibiotics, Treatment/therapy, Bacterial, Mastitis, Mammary gland/udder, Infectious disease, Milk, Disease/defect
Article class: Scientific Article
Abstract: Two dry-cow therapy products were evaluated in seven factory-supply dairy herds in the Waikato area. A product containing neomycin sulphate and the benzathine salt of penicillin (Neopen D.C. White; Smith-Biolab) was used in five herds, and one containing benzathine cloxacillin (Orbenin, Beecham) was used in two herds. Non-treated control cows were included in each herd. Both products were effective in eliminating intramammary infections with Staphylococcus aureus, Streptococcus uberis, and Streptococcus agalactiae. Efficacy of dry-cow therapy against S. aureus was 83.8% and 85.2% respectively. Spontaneous cure rate among controls was 30.8% for S. aureus during the dry period. Spontaneous cure rate for Str. uberis was 50%, while dry-cow therapy eliminated 100% and 77.8%, respectively, for the two products. Dry-cow therapy with either product eliminated more tlhan 90% of Str. agalactiae infections while spontaneous cure rate was only 28.6%. These results further support the effectiveness of dry-cow therapy in reducing the level of subclinical mastitis in dairy herds by shortening the duration of intramammary infections.
Access to the full text of this article is available to members of:
- SciQuest - Complimentary Subscription
Login
Otherwise:
Register for an account